Form 8-K - Current report:
SEC Accession No. 0001564590-21-051756
Filing Date
2021-10-25
Accepted
2021-10-25 17:12:06
Documents
12
Period of Report
2021-10-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K NOVEMBER imra-8k_20211021.htm   iXBRL 8-K 35173
  Complete submission text file 0001564590-21-051756.txt   166410

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA imra-20211021.xsd EX-101.SCH 5665
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE imra-20211021_lab.xml EX-101.LAB 20078
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imra-20211021_pre.xml EX-101.PRE 11919
5 EXTRACTED XBRL INSTANCE DOCUMENT imra-8k_20211021_htm.xml XML 3665
Mailing Address 116 HUNTINGTON AVENUE 6TH FLOOR BOSTON MA 02116
Business Address 116 HUNTINGTON AVENUE 6TH FLOOR BOSTON MA 02116 617-206-2020
IMARA Inc. (Filer) CIK: 0001672619 (see all company filings)

EIN.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39247 | Film No.: 211344977
SIC: 2834 Pharmaceutical Preparations